Abrams Research Center on Neurogenomics

The ARC at Northwestern University is dedicated to advancing Alzheimer’s disease research with sophisticated genomics tools and AI analytics.

[Abrams Research Center on Neurogenomics @ARC_Neuro]

Hello world! We are the ARC at Northwestern University's Feinberg School of Medicine. We are a team of researchers focused on solving Alzheimer's disease. Some photos from our ribbon cutting in October.

[David Gate @DGateLab]

Excited to share our latest work on ALS neuroimmunology, published today in @NatureNeuro https://t.co/Ewdf2a4ge2

[Abrams Research Center on Neurogenomics @ARC_Neuro]

The ARC is looking forward to partnering with @TempusAI to use the power of AI in our fight against Alzheimer’s disease.

[Tempus @TempusAI]

We are proud to announce a collaboration with @ARC_Neuro at Northwestern University Feinberg School of Medicine to harness AI for rapid discovery and innovation in Alzheimer’s disease research. Using Lens, the Center and Tempus teams will work together to uncover genomic patterns that have the potential to advance the understanding of Alzheimer’s disease, investigate the gene and cell types affected, enable the development of new therapeutics, and accelerate the creation of novel clinical applications.

Learn more: https://t.co/m0ZEWjK9qc

[Hamilton Oh @hammy_oh]

I am excited to present our new study out in @NatureMedicine where we discover a novel synaptic protein biomarker to predict if and when someone will get Alzheimer’s disease dementia. Part 2/3 from my PhD work in the @wysscoray lab. 🧵1/12

Full study 🔗: https://t.co/yg8lmRXuTN

[David Gate @DGateLab]

It’s quite an experience to have some of your favorite labs like ⁦@TheColonnaLab⁩ and ⁦@Haass_Lab⁩ comment on your lab’s research. Great reporting by Alzforum! https://t.co/vtERMRGhyU

[Alzforum @alzforum]

In brains of people immunized against Aβ, postmortem omics reveal microglial plaque clearing pathways. @NorthwesternU https://t.co/aKkrYJUioJ

[David Gate @DGateLab]

This Northwestern Breakthroughs podcast nicely encapsulates our study. The host does a great job leading the discussion for the lay audience to digest our work. I hope this allows people to better understand the results and impact of this study. https://t.co/9v3MwmIr68

[Northwestern @NorthwesternU]

Alzheimer’s treatment may lie in the brain’s cleanup crew 🧠

For decades, scientists have worked to stop Alzheimer’s disease by removing amyloid beta plaques. Now, a @NorthwesternMed study finds the brain’s own immune cells can clear them more effectively.

[Northwestern Medicine @NorthwesternMed]

The team at Abrams Research Center on Neurogenomics, led by @DGateLab, is excited to explore their new lab! Using #ArtificialIntelligence, genetic research and global collaborations, they’re advancing Alzheimer’s disease research. #NMBetter

[David Gate @DGateLab]

This video describes the findings from our recent study conducted at ⁦@ARC_Neuro⁩. In the video, lead author ⁦@LynnOlst⁩ and I discuss the findings and their implications for Alzheimer’s disease. https://t.co/qUZbFpo5FZ

[Abrams Research Center on Neurogenomics @ARC_Neuro]

アルツハイマー病の治療は脳自身のクリーンアップクルーにあるかもしれません https://t.co/jpqYHXZ0oN

[Nature Medicine @NatureMedicine]

Spatial transcriptomics reveals distinct microglial mechanisms driving amyloid-β clearance in both passive and actively immunized #Alzheimer’s disease patients @NUFeinbergMed
https://t.co/DirVOwGV5r

[Lynn van Olst @LynnOlst]

Excited to share our latest @NatureMedicine study from our new center @ARC_Neuro! 🧠✨ Using spatial transcriptomics & scRNA-seq, we uncover how Aβ-targeting immunotherapies shape microglial responses in AD patient brains.

A thread with our key findings is below! 🧵(1/15)